MentionFoxFibroBiologics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-13.
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns FibroBiologics, Inc.
Free to see. No signup.
We'll show it in your MentionFox inbox when FibroBiologics, Inc. raises, hires or launches. No email unless you switch it on.
Watch FibroBiologics, Inc. →Get the full cited report on FibroBiologics, Inc.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on FibroBiologics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for FibroBiologics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $1.20M, on the same scale — one filing against the whole group's total, so it sits low by construction.
The issuer intends to use the net proceeds from this offering for working capital and general corporate purposes.
On the filing as: Executive Officer, Director.
Pete O'Heeron is named as Chief Executive Officer on the Form D that FibroBiologics, Inc. filed with the SEC on 13 October 2026, one of 9 people that filing names.
Richard Cilento is named as Director on the Form D that FibroBiologics, Inc. filed with the SEC on 13 October 2026, one of 9 people that filing names.
Robert Hoffman is named as Director on the Form D that FibroBiologics, Inc. filed with the SEC on 13 October 2026, one of 9 people that filing names.
Victoria Niklas is named as Director on the Form D that FibroBiologics, Inc. filed with the SEC on 13 October 2026, one of 9 people that filing names.
Kathleen Rubins is named as Director on the Form D that FibroBiologics, Inc. filed with the SEC on 13 October 2026, one of 9 people that filing names.
Leigh Steinberg is named as Director on the Form D that FibroBiologics, Inc. filed with the SEC on 13 October 2026, one of 9 people that filing names.
On the filing as: Executive Officer.
Jason Davis is named as Chief Financial Officer on the Form D that FibroBiologics, Inc. filed with the SEC on 13 October 2026, one of 9 people that filing names.
On the filing as: Executive Officer.
Ruben Garcia is named as General Counsel on the Form D that FibroBiologics, Inc. filed with the SEC on 13 October 2026, one of 9 people that filing names.
On the filing as: Executive Officer.
Hamid Khoja is named as Chief Scientific Officer on the Form D that FibroBiologics, Inc. filed with the SEC on 13 October 2026, one of 9 people that filing names.
9 people named on the filing — 4 holding an executive role and 5 as directors only.
Named as of the 2026-10-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on FibroBiologics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on FibroBiologics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist FibroBiologics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind FibroBiologics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for FibroBiologics, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/fibrobiologics-inc-form-d-046663